Last reviewed · How we verify
Ticagrelor vs Clopidogrel — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Ticagrelor vs Clopidogrel (Ticagrelor vs Clopidogrel) — Fundación Investigación Sanitaria en León.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ticagrelor vs Clopidogrel TARGET | Ticagrelor vs Clopidogrel | Fundación Investigación Sanitaria en León | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ticagrelor vs Clopidogrel CI watch — RSS
- Ticagrelor vs Clopidogrel CI watch — Atom
- Ticagrelor vs Clopidogrel CI watch — JSON
- Ticagrelor vs Clopidogrel alone — RSS
Cite this brief
Drug Landscape (2026). Ticagrelor vs Clopidogrel — Competitive Intelligence Brief. https://druglandscape.com/ci/ticagrelor-vs-clopidogrel. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing